Drug Consumption Rooms as a setting to address HCV: Current Practice and Future Capacity 2018

Correlation - European Harm Reduction Network (2019)

While decreases in risky injecting behaviours are an outcome of DCR use, HCV prevention and treatment in these settings haven’t been adequately described. There are no international DCR standards for HCV practice and surveys are yet to address HCV prevention, treatment or sero-prevalence status of DCR clients. This online survey provides a ‘snapshot’ of DCR clients’ HCV status; approaches to HCV in DCRs, and what DCRs need to expand these services.

Drug Consumption Rooms as a setting to address HCV: Current Practice and Future Capacity 2018

Drug Consumption Rooms as a setting to address HCV: Current Practice and Future Capacity 2018

PDF Document
English 489 PDF Document
In partnership with:
ISFF
FUAS
Correlation Network